EGLN3 and neoplasm: This appears to be at least in part mediated through a decreased expression of PHD3, a prolyl hydroxylase which is relevant in regulating fatty acid oxidation; decreasing PHD3 expression by tumor cells can relieve the suppression of fatty acid transport to the mitochondria, resulting in increased beta-oxidation and ATP production.